NASD · Healthcare · Diagnostics & Research · USA
Freenome Inc is a small cap company (market value between $300 million and $2 billion) in the Diagnostics & Research industry.
Freenome Inc is a blank check company formed to execute a merger with a healthcare-focused business. The firm has generated no revenues to date and is currently searching for acquisition candidates in the life sciences and medical technology industries, primarily in North America and Europe. Its management team has experience identifying and acquiring companies in the healthcare sector.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Freenome Inc stock.
Not valued: We cannot value this company yet.
We do not publish a value for this company: it has no growth history of its own to project.
All 44 Diagnostics & Research stocks
23 more in this industry show a wider margin of safety.
We do not publish a verdict on FRNM yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history. We do not have it. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.
We do not publish one (as of the 2026-11-17 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history. We do not have it. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.